“When we own portions of outstanding businesses with outstanding managements, our favorite holding period is forever.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a two-decade holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Abbott Laboratories (NYSE: ABT)? Today, we examine the outcome of a two-decade investment into the stock back in 2003.
|Average annual return:||11.27%|
As shown above, the two-decade investment result worked out quite well, with an annualized rate of return of 11.27%. This would have turned a $10K investment made 20 years ago into $84,711.61 today (as of 09/27/2023). On a total return basis, that’s a result of 747.35% (something to think about: how might ABT shares perform over the next 20 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
Beyond share price change, another component of ABT’s total return these past 20 years has been the payment by Abbott Laboratories of $21.15/share in dividends to shareholders. Automatic reinvestment of dividends can be a wonderful way to compound returns, and for the above calculations we presume that dividends are reinvested into additional shares of stock. (For the purpose of these calcuations, the closing price on ex-date is used).
Based upon the most recent annualized dividend rate of 2.04/share, we calculate that ABT has a current yield of approximately 2.14%. Another interesting datapoint we can examine is ‘yield on cost’ — in other words, we can express the current annualized dividend of 2.04 against the original $19.10/share purchase price. This works out to a yield on cost of 11.20%.
Here’s one more great investment quote before you go:
“In the short run, the market is a voting machine but in the long run, it is a weighing machine.” — Benjamin Graham